Novo Nordisk CEO on Insulin Drug Pricing
Novo Nordisk CEO: "We are very encouraged by growth momentum" — MedWatch
A massive market beckons, but Novo CEO sees shared purpose in obesity
Novo Nordisk Forecasts Record Profit Fueled by Obesity Drug - Bloomberg
Watch Novo Nordisk CEO Lars Fruergaard Jorgensen on Coronavirus Outbreak, Earnings, 2020 Outlook - Bloomberg
Novo Nordisk Raises Forecasts on New Obesity Drug - Video - BNN
Novo Nordisk CEO on EU pharma reform: "A lose, lose, lose" — MedWatch
Novo Nordisk extends commitment to China - SHINE News
Novo Nordisk's new CEO leads it through its first tough period – European CEO
Novo Nordisk's CEO: If it was easy to correct pricing, we'd do it- STAT
Lars Fruergaard Jorgensen a model for 'Novo Nordisk Way' | Financial Times
Novo Nordisk and the University of Toronto announce joint investment - Nordic Life Science – the leading Nordic life science news service
Pharma CEO: Gap between EU vision and national competencies affects health agenda – EURACTIV.com
Novo Nordisk boss Lars Fruergaard Jorgensen: We bring hope in the war on obesity
Lars Fruergaard Jørgensen – President & CEO at Novo Nordisk – Novo Nordisk | LinkedIn
Executive Management
Novo Nordisk on Twitter: "Vores CEO Lars Fruergaard Jørgensen er formand for regeringens klimapartnerskab for life science og biotek. Vi ser frem til samarbejdet om at bidrage til regeringens ambitiøse 2030-målsætning 🌎💪#dkgreen #
Novo Nordisk-boss belønnes: Her er hans vilde løn | BT Erhverv - www.bt.dk
